Startups
Micell Technologies is an innovative technology company dedicated to transforming medical devices for improved patient outcomes. The Company’s supercritical fluid technology is a key component in its enhanced drug delivery system, which is currently in use within the interventional cardiology market, though the technology has potentially far-reaching applications for treating cardiovascular disease. Focused on eliminating some of the primary limitations typical of existing technologies used to create drug-eluting medical devices, Micell is committed to bringing this unique approach to market.
The Company’s flagship product, MiStent® SES, is a CE-marked drug-eluting stent that is currently available for sale in many countries around the world. In Europe, MiStent SES can be purchased through our distribution partner, STENTYS. MiStent SES is not approved for sale or use within the United States.
The Company’s flagship product, MiStent® SES, is a CE-marked drug-eluting stent that is currently available for sale in many countries around the world. In Europe, MiStent SES can be purchased through our distribution partner, STENTYS. MiStent SES is not approved for sale or use within the United States.
Overview
Location
United States
Employees
11-50
Founded date
1995
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 19, 2017 | Durham-based Micell Technologies Raises another $20 Million | Micell Technologies Inc., a Durham-based biotech company, raised an additional $20 million in an equity and debt offering, according to a filing with the Security and Exchange Commission on Tuesday. It was not disclosed what the company int... |
| Apr 5, 2017 | Durham-based Micell Technologies Raises another $6 Million | Micell Technologies, a Durham based company, raised an additional $6 million in a private stock offering, according to a Securities and Exchange Commission filing. The company filed the Form D on April 4. In November 2016, Micell also raise... |
| Apr 5, 2017 | Durham-based Micell Technologies Raises another $6 Million | Micell Technologies, a Durham based company, raised an additional $6 million in a private stock offering, according to a Securities and Exchange Commission filing. The company filed the Form D on April 4. In November 2016, Micell also raise... |
| Sep 21, 2009 | USA, Micell Receives $15 Million Equity Investment | Raleigh, NC.-based Micell Technologies, a development-stage biomedical company dedicated to developing innovative interventional cardiology systems, announced today that St. Jude Medical, Inc. has made a $15m equity investment in the compan... |
| Jul 12, 2007 | Micell: A materials chameleon tackles drug-coated devices | For Micell Technologies, a Raleigh, N.C., materials company that recently reinvented itself as a developer of drug-releasing stents, perhaps the third time will be the charm. Founded in 1995, Micell specializes in the use of supercritical f... |
Reviews 0
FAQ about Micell Technologies, Inc.
When was Micell Technologies, Inc. founded?
Micell Technologies, Inc. was founded in 1995.
What has the press written about Micell Technologies, Inc.?
Parsers VC has collected 6 articles mentioning Micell Technologies, Inc., among them “Durham-based Micell Technologies Raises another $20 Million” (Sep 19, 2017) and “Durham-based Micell Technologies Raises another $6 Million” (Apr 5, 2017).
Is Micell Technologies, Inc. still active?
Yes, Micell Technologies, Inc. is active; its latest activity on Parsers VC dates from Sep 19, 2017.